TickerFacts.

A business in context

TVTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-02 · 0001943192-26-000005

  2. 4 · Ownership change

    Report date 2026-08-17 · 0001123343-26-000010

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001438533-26-000063

  4. 8-K · Current report

    Report date 2026-08-04 · 0001438533-26-000062 · Items 2.02,9.01

  5. 8-K · Current report

    Report date 2026-07-06 · 0001438533-26-000054 · Items 5.02

  6. 4 · Ownership change

    Report date 2026-06-22 · 0001902368-26-000007

  7. 4 · Ownership change

    Report date 2026-06-12 · 0001680739-26-000014

  8. 8-K · Current report

    Report date 2026-06-12 · 0001438533-26-000048 · Items 5.02

  9. 4 · Ownership change

    Report date 2026-06-12 · 0001376043-26-000010

  10. 8-K · Current report

    Report date 2026-06-01 · 0001193125-26-252474 · Items 1.01,9.01

  11. 4 · Ownership change

    Report date 2026-05-19 · 0001680739-26-000012

  12. 4 · Ownership change

    Report date 2026-05-19 · 0001619622-26-000002

  13. 4 · Ownership change

    Report date 2026-05-19 · 0001517790-26-000002

  14. 8-K · Current report

    Report date 2026-05-19 · 0001438533-26-000046 · Items 5.02,5.07,9.01

  15. 8-K · Current report

    Report date 2026-05-06 · 0001193125-26-217100 · Items 1.01,2.03,3.02,8.01,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001438533-26-000042

  17. 8-K · Current report

    Report date 2026-05-04 · 0001438533-26-000041 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-04-13 · 0001438533-26-000032 · Items 8.01

  19. DEF 14A · Proxy statement

    Report date 2026-05-19 · 0001438533-26-000027

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001438533-26-000014

  21. 8-K · Current report

    Report date 2026-02-19 · 0001438533-26-000013 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-01-13 · 0001438533-26-000005 · Items 8.01

  23. 8-K · Current report

    Report date 2026-01-12 · 0001438533-26-000003 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001438533-25-000056

  25. 8-K · Current report

    Report date 2025-10-30 · 0001438533-25-000055 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-09-10 · 0001438533-25-000049 · Items 8.01

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001438533-25-000046

  28. 8-K · Current report

    Report date 2025-08-06 · 0001438533-25-000045 · Items 2.02,9.01

  29. 8-K · Current report

    Report date 2025-05-15 · 0001438533-25-000034 · Items 5.02,5.07,9.01

  30. 8-K · Current report

    Report date 2025-05-15 · 0001438533-25-000032 · Items 8.01

  31. 8-K/A · Current report

    Report date 2025-05-01 · 0001438533-25-000030 · Items 2.02,9.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001438533-25-000026

  33. 8-K · Current report

    Report date 2025-05-01 · 0001438533-25-000025 · Items 2.01,9.01

  34. 8-K · Current report

    Report date 2025-04-29 · 0001438533-25-000020 · Items 8.01

  35. DEF 14A · Proxy statement

    Report date 2025-05-15 · 0001438533-25-000016

  36. 8-K · Current report

    Report date 2025-03-17 · 0001438533-25-000012 · Items 8.01

  37. 10-K · Annual report

    Report date 2024-12-31 · 0001438533-25-000010

  38. 8-K · Current report

    Report date 2025-02-20 · 0001438533-25-000008 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2025-02-11 · 0001438533-25-000004 · Items 8.01

  40. 8-K · Current report

    Report date 2025-01-13 · 0001438533-25-000002 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 40 transaction rows40SGrant / award: 30 transaction rows30AExercise / conversion: 56 transaction rows56MTax / exercise payment: 0 transaction rows0FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

127 matching transaction rows. Showing 101–127.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock7215.041.93
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock7500.015.46
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.019.08
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock20000.017.96
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee stock option (right to buy)
Derivative security
7500.00.0
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee stock option (right to buy)
Derivative security
10000.00.0
2026-04-14
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee stock option (right to buy)
Derivative security
20000.00.0
2026-04-14
2026-04-16
LYONS GARY A
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock8000.041.07
2026-04-14
2026-04-16
LYONS GARY A
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock8000.016.33
2026-04-14
2026-04-16
LYONS GARY A
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Stock option (right to buy)
Derivative security
8000.00.0
2026-04-13
2026-04-15
Cline Christopher R.
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock14000.00.0
2026-04-13
2026-04-15
Cline Christopher R.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock65.028.85
2026-04-13
2026-04-15
Inrig Jula
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock14000.00.0
2026-04-13
2026-04-15
Heerma PeterA · Grant / award
Acquired
Common Stock14000.00.0
2026-04-13
2026-04-15
Dube Eric M
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock64000.00.0
2026-04-13
2026-04-15
ROTE WILLIAM E.
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock14000.00.0
2026-04-13
2026-04-15
REED ELIZABETH E
10b5-1 checkbox reported
A · Grant / award
Acquired
Common Stock14000.00.0
2026-04-06
2026-04-07
Baynes Roy D.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10000.033.0
2026-04-06
2026-04-07
Baynes Roy D.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.026.52
2026-04-06
2026-04-07
Baynes Roy D.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock option (right to buy)
Derivative security
10000.00.0
2026-04-01
2026-04-02
Dube Eric M
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock25098.031.46
2026-04-01
2026-04-02
Dube Eric M
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock34902.030.55
2026-04-01
2026-04-02
Dube Eric M
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock60000.015.46
2026-04-01
2026-04-02
Dube Eric M
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee stock option (right to buy)
Derivative security
60000.00.0
2026-04-01
2026-04-02
REED ELIZABETH E
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10000.030.0
2026-04-01
2026-04-02
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.015.46
2026-04-01
2026-04-02
REED ELIZABETH E
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee stock option (right to buy)
Derivative security
10000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001438533Travere Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names
  • Retrophin, Inc. · former SEC name · 2013-02-21 to 2020-11-13
  • Desert Gateway, Inc. · former SEC name · 2008-06-27 to 2013-02-19

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$233.18M$248.21M
2023-12-31$145.24M$159.15M
2022-12-31$109.46M$124.87M
2021-12-31$131.84M$162.43M
2020-12-31$198.32M$255.87M
2019-12-31$175.34M$229.00M
2018-12-31$164.25M$218.40M
2017-12-31$154.94M$211.06M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗